The effects of family history and personal experiences of illness on the inclination to change health-related behaviour
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
19418712
DOI
10.21101/cejph.a3506
Knihovny.cz E-resources
- MeSH
- Risk Reduction Behavior * MeSH
- Exercise MeSH
- Cardiovascular Diseases psychology MeSH
- Middle Aged MeSH
- Humans MeSH
- Obesity psychology MeSH
- Smoking Cessation MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- Educational Status MeSH
- Health Behavior * MeSH
- Health Knowledge, Attitudes, Practice * MeSH
- Family Health MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Poland MeSH
- Sweden MeSH
The aim of the present study was to examine how a personal experience of illness and a family history of cardiovascular disease (CVD), adjusted for sex, level of education and nationality, affect risk behaviour. Participants were 1,011 and 1,043, 50-year-old men and women from Sweden and Poland, respectively, who were recruited from a primary health care screening programme. Family history, personal experience of illness and risk behaviour (smoking and exercise habits, BMI level) were self-reported. The results showed that smoking behaviour was affected by a personal experience of illness but not by a family history of CVD. No effects of these variables were found on the remaining risk-related variables tested in this study. These results suggest that individuals with a personal experience of illness may be more inclined to change smoking behaviour than the average person. Smoking prevention strategies may therefore benefit from targeting this group in particular.
See more in PubMed
Int J Clin Pharmacol Ther. 2004 Feb;42(2):103-9 PubMed
Dis Manag. 2007 Oct;10(5):273-84 PubMed
Z Kardiol. 2004 Jan;93(1):72-90 PubMed
Control Clin Trials. 2000 Oct;21(5 Suppl):184S-7S PubMed
JAMA. 1999 Jun 9;281(22):2075-6 PubMed
Eur Heart J. 2006 Oct;27(19):2285-93 PubMed
Cerebrovasc Dis. 2003;15(4):282-8 PubMed
Eur J Clin Pharmacol. 2005 Jan;60(11):797-805 PubMed
JAMA. 1998 Aug 19;280(7):623-9 PubMed
Eur Heart J. 2002 Dec;23(23):1809-40 PubMed
Int J Clin Pharmacol Ther. 2003 Feb;41(2):77-82 PubMed
Z Kardiol. 2004 Apr;93(4):324-41 PubMed
N Engl J Med. 2001 Aug 16;345(7):494-502 PubMed
Eur Heart J. 2001 Oct;22(19):1794-801 PubMed
Dtsch Med Wochenschr. 2007 Nov;132(45):2367-70 PubMed
Z Kardiol. 2001 Jun;90(6):394-400 PubMed
J Am Coll Cardiol. 2002 Oct 2;40(7):1366-74 PubMed
Eur J Clin Pharmacol. 2005 Jul;61(5-6):433-8 PubMed
Eur Heart J. 2005 Apr;26(8):804-47 PubMed
Gesundheitswesen. 1997 Apr;59(4):258-61 PubMed
Lancet. 2001 Mar 31;357(9261):995-1001 PubMed
